Philip Toleikis
Corporate Officer/Principal at Medway Working Group
Net worth: 1 M $ as of 2024-05-30
Profile
Philip M.
Toleikis is a Member of the Medway Working Group.
He previously worked as the Director & Chief Technology Officer at Sernova Corp.
from 2023 to 2024 and as the VP-Pharmacology, Research & Development at Angiotech Pharmaceuticals, Inc. in 2006.
Dr. Toleikis holds a doctorate degree from the University of British Columbia, a graduate degree from the University of Michigan, and an undergraduate degree from the University of Vermont.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SERNOVA CORP.
1.74% | 2023-04-24 | 5,273,598 ( 1.74% ) | 1 M $ | 2024-05-30 |
Philip Toleikis active positions
| Companies | Position | Start |
|---|---|---|
| Medway Working Group | Corporate Officer/Principal | - |
Former positions of Philip Toleikis
| Companies | Position | End |
|---|---|---|
| SERNOVA CORP. | Chief Executive Officer | 2023-09-04 |
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | 2005-12-31 |
Training of Philip Toleikis
| University of British Columbia | Doctorate Degree |
| University of Michigan | Graduate Degree |
| University of Vermont | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SERNOVA CORP. | Health Technology |
| Private companies | 2 |
|---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
| Medway Working Group |
- Stock Market
- Insiders
- Philip Toleikis
